Photo of Joel Levine, M.D.

Joel Levine, M.D.

Professor of Medicine
Co-Director and Founding Director, Colon Cancer Prevention Program
NPI Number:
1942206156
Academic Office Location:
Medicine
UConn Health
263 Farmington Avenue
Farmington, CT 06030-2813
Phone: 800-535-6232
860-679-7692

  • Looking for a Physician?

    This faculty member is also
    a practicing physician at UConn Health.

    Learn more >
Education
DegreeInstitutionMajor
M.D.State University of New York Health Science CenterMedicine

Post-Graduate Training
TrainingInstitutionSpecialty
InternshipUniversity of Chicago HospitalsMedicine
ResidencyUniversity of Chicago HospitalsMedicine
Clinical AssociateNational Cancer Institute, NIHClinical Associate
ResidencyMassachusetts General Hospital, Harvard Medical SchoolMedicine, Senior Resident
FellowshipMassachusetts General Hospital, Harvard Medical SchoolMedicine, Clinical Fellow
FellowshipMassachusetts General Hospital, Harvard Medical SchoolMedicine, Research Fellow

Awards
Name of Award/HonorAwarding Organization
Top Doctors (U.S. and Northeast U.S.) 2009, 2010
Top Doctors for Women (Top 5 in Northeast U.S.)
“Top Doctors for Cancer” Top Doctor Gastroenterology (Top 5 in Northeast U.S.) 2006-2013Connelly Castle Ltd.
Top Doctors in Cancer, 2006, 2007, 2010
Best Doctors (U.S.) 1996 to 2013
Best Lecturer, Advances in Internal Medicine Course, 1979, 1982, 1984, 1985, 1987

Journal Articles

Abstracts

  • Randomized phase II trial of sulindac, atorvastatin, and prebiotic dietary fiber for colorectal cancer chemoprevention.
    Limburg, Paul J; Mahoney, Michelle R; Ziegler, Katie L Allen; Sontag, Stephen J; Schoen, Robert E; Benya, Richard; Lawson, Michael J; Weinberg, David S; Stoffel, Elena; Chiorean, Michael; Heigh, Russell; Levine, Joel; Della'Zanna, Gary; Rodriguez, Luz; Richmond, Ellen; Gostout, Christopher; Mandrekar, Sumithra J; Smyrk, Thomas C Cancer prevention research (Philadelphia, Pa.) 2011 Jan;4(2):259-69
  • Soluble triggering receptor expressed on myeloid cells (sTREM-1): a new mediator involved in the pathogenesis of peptic ulcer disease.
    Koussoulas, Vassilios; Vassiliou, Spyridon; Demonakou, Maria; Tassias, Georgios; Giamarellos-Bourboulis, Evangelos J; Mouktaroudi, Maria; Giamarellou, Helen; Barbatzas, Charalambos European journal of gastroenterology & hepatology 1988 Jan;18(4):375-9
  • Observations on the ratio of portal/total liver blood flow In disease and after splenorenal shunting.
    Spencer RP, Mozafareddin K, Karimeddini MK, Levine JB, Levy HA Annual Meeting of FASEB 1983 Jan;
  • Activated coagulation in Crohn's disease: Serial observations of plasma fibrinopeptide (FPA) in disease activity.
    Levine JB, Edwards R, Rickles F American Gastroenterological Association Meeting 1981 Jan;
  • Changes in coagulation activation as measured by plasma fibrinopeptide A (FPA) following therapy in patients with active Crohn's disease.
    Duffy M, Cronlund M, Levine JB Gastroenterology 1979 Jan;761126
  • Fibrinopeptide-A (FPA) in plasma of patients with Crohn's disease as evidence of hypercoaguability: Correlation with the Crohn's Disease Activity Index (CDAI)
    Green R, Pogue W, Cronlund M, Levine JB Gastroenterology 1978 Jan;741041
  • Histidine-mediated decreases in total body zinc and urinary prophyrins and porphyrin precursors in two types of hepatic porphyria.
    Levine JB, Aamodt R, Tschudy DP, Henkin R J Clin Invest 1973 Jan;

Other

Reviews

Short Surveys

  • A "perfect storm".
    Deckers, Peter J; Levine, Joel Connecticut medicine 2007 Jan;71(1):53-5
Title or AbstractTypeSponsor/EventDate/YearLocation
Correlation of 25 OH Vitamin D with Advanced AdenomasOtherAmerican College of Gastroenterology (ACG) Annual Meeting2010